Asset Details
Do you wish to reserve the book?
Small molecule compound ZYZ-384 targets SMYD3 to alleviate aging
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Small molecule compound ZYZ-384 targets SMYD3 to alleviate aging
Do you wish to request the book?
Small molecule compound ZYZ-384 targets SMYD3 to alleviate aging
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Small molecule compound ZYZ-384 targets SMYD3 to alleviate aging
2025
Overview
SMYD3 is a chromatin modifier that facilitates the trimethylation of histone 3 lysine 4 (H3K4) to induce diverse biological activities. We have provided a brief demonstration of the anti-aging effect of ZYZ-384, a newly developed inhibitor targeting SMYD3. In order to validate the anti-senescence effect of ZYZ-384, we utilized angiotensin II to induce senescence in two types of human endothelial cells (HMEC-1) and mouse endothelial cells (SVEC4-10), creating cellular models for senescence. Additionally, we employed D-galactose-induced subacute senescence animal models as well as natural senescence animal models. At the cellular level, we assessed proliferation capacity and intracellular markers associated with aging. Aging markers, SASP and differential metabolites were evaluated at an organismal level using animal models. Compared to senescent cells or animals, ZYZ-384 application significantly inhibited levels of aging markers in both senescent cell and senescent animal models while promoting cell proliferation. Furthermore, it suppressed expression of SMYD3 and H3K4me3 along with over expression of HSP 90 and NF-κB. Our study demonstrates that ZYZ-384 is an effective inhibitor targeting SMYD3 which can effectively delay aging.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 692/308
/ 692/699
/ Age
/ Aging
/ Animals
/ Cell Proliferation - drug effects
/ Cellular Senescence - drug effects
/ Endothelial Cells - drug effects
/ Endothelial Cells - metabolism
/ Enzymes
/ Genes
/ Histone-Lysine N-Methyltransferase - antagonists & inhibitors
/ Histone-Lysine N-Methyltransferase - metabolism
/ Histones
/ Humanities and Social Sciences
/ Humans
/ Mice
/ Proteins
/ Science
